Yunn-Kuen Chang

Title: Yunn-Kuen Chang: Innovator in Tissue Adhesion Prevention

Introduction

Yunn-Kuen Chang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of compositions aimed at preventing tissue adhesions. With a total of 2 patents, his work is recognized for its innovative approach to medical applications.

Latest Patents

Chang's latest patents include two notable inventions. The first is a "Temperature sensitive composition for tissue adhesion prevention and application thereof." This invention relates to a composition that comprises an amino acid-modified polymer and a carboxypolysaccharide, which may further include a metal ion for anti-adhesion and vector application. The thermosensitive composition is designed to have enhanced mechanical properties and improved water-erosion resistance, making it effective in preventing tissue adhesions while being bio-compatible and biodegradable.

The second patent is titled "Amino acid-modified polymer for adhesion prevention and application thereof." This patent discloses synthetic amino acid-modified polymers and methods for their production and use. These polymers exhibit distinct thermosensitive properties, improved water-erosion resistance, and enhanced mechanical characteristics, making them suitable for reducing or preventing postoperative tissue adhesions. Additionally, they can serve as vectors for delivering pharmaceutically active agents.

Career Highlights

Yunn-Kuen Chang is currently associated with Proview-MBD Biotech Co., Ltd., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential to improve surgical outcomes and patient care.

Collaborations

Chang collaborates with notable colleagues, including Yu-Chia Chang and Wen-Yen Huang, who contribute to his research and development efforts.

Conclusion

Yunn-Kuen Chang's contributions to the field of tissue adhesion prevention through his innovative patents highlight his role as a leading inventor in biotechnology. His work not only advances medical technology but also has the potential to significantly improve patient outcomes.